ASHLEY OLSON: Open Payments
NPI 1356195697 · ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,827 in 222 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,994 · 2025 $5,827
Food & beverage: $5,590Education: $174Travel & lodging: $63
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 28 | $1,128 |
| ABBVIE INC. | 30 | $704 |
| Janssen Biotech, Inc. | 13 | $687 |
| Arcutis Biotherapeutics, Inc. | 16 | $478 |
| Galderma Laboratories, L.P. | 22 | $430 |
| Amgen Inc. | 13 | $359 |
| PFIZER INC. | 13 | $334 |
| Incyte Corporation | 18 | $313 |
| GENZYME CORPORATION | 15 | $299 |
| Lilly USA, LLC | 14 | $253 |
Products named: Bimzelx, TREMFYA, SKYRIZI, DUPIXENT, Zoryve, OTEZLA, NEMLUVIO, OPZELURA.
Industry payments across MA — which companies pay providers there.
